Danielle Miller
Papers
1
Total Citations
6
H-Index
1
About
Dr. Danielle Miller is a leading biotechnologist whose work focuses on the analytical characterization and quality control of next-generation mRNA therapeutics. Her primary research addresses the critical challenge of ensuring the safety and efficacy of mRNA vaccines by detecting and quantifying process-related impurities. Her most impactful contribution is the development and application of an automated Sandwich ELISA assay for quantitating residual double-stranded RNA (dsRNA) in mRNA vaccines. This work is foundational, as dsRNA is a known immunostimulatory impurity generated during in vitro transcription that can compromise vaccine potency and patient safety. Her 2024 paper on this method has already garnered 6 citations, highlighting its immediate relevance to the pharmaceutical industry. By providing a robust, high-throughput quality control tool, Dr. Miller’s research directly enables the scalable, safe manufacturing of mRNA vaccines, a technology now critical for confronting global disease. Her achievements place her at the forefront of ensuring the reliability of this revolutionary vaccine platform.
Research Focus
Key Achievements
Top Papers
- 1